Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-028127
Filing Date
2019-05-07
Accepted
2019-05-07 19:58:25
Documents
1
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5210
  Complete submission text file 0001209191-19-028127.txt   6586
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address
Walker Paul Edward (Reporting) CIK: 0001553150 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 19804812

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations